Suppr超能文献

急性卒中后患者体内的肿瘤坏死因子相关凋亡诱导配体(TRAIL):与卒中严重程度、心肌损伤的关系及对预后的影响

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Patients after Acute Stroke: Relation to Stroke Severity, Myocardial Injury, and Impact on Prognosis.

作者信息

Mihalovic Michal, Mikulenka Petr, Línková Hana, Neuberg Marek, Štětkářová Ivana, Peisker Tomáš, Lauer David, Tousek Petr

机构信息

Cardiocenter, Third Faculty of Medicine, Charles University, 100 34 Prague, Czech Republic.

Department of Neurology, Third Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University, 100 34 Prague, Czech Republic.

出版信息

J Clin Med. 2022 May 2;11(9):2552. doi: 10.3390/jcm11092552.

Abstract

BACKGROUND

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is known to be associated with poor prognosis after cardiovascular events. We aimed to assess the dynamic changes in TRAIL levels and the relation of TRAIL level to stroke severity, its impact on the short-term outcomes, and its association with markers of cardiac injury in patients after acute stroke.

METHODS

Between August 2020 and August 2021, 120 consecutive patients, 104 after acute ischemic stroke (AIS), 76 receiving reperfusion therapy, and 16 patients after intracerebral hemorrhage (ICH) were enrolled in our study. Blood samples were obtained from patients at the time of admission, 24 h later, and 48 h later to determine the plasma level of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), N-terminal prohormone of brain natriuretic peptide (NT-proBNP), and high-sensitive Troponin I (hs-TnI). Twelve-lead ECGs were obtained at the time of admission, 24 h later, 48 h later, and at the release of the patients. Evaluations were performed using the National Institutes of Health Stroke Scale (NIHSS) at the time of admission and using the modified Rankin Scale (mRS) 90 days following the patient's discharge from the hospital.

RESULTS

We observed a connection between lower TRAIL levels and stroke severity evaluated using the NIHSS ( = 0.044) on the first day. Lower TRAIL showed an association with severe disability and death as evaluated using the mRS at 90 days, both after 24 ( = 0.0022) and 48 h ( = 0.044) of hospitalization. Moreover, we observed an association between lower TRAIL and NT-proBNP elevation at the time of admission ( = 0.039), after 24 ( = 0.043), and after 48 h ( = 0.023) of hospitalization. In the ECG analysis, lower TRAIL levels were associated with the occurrence of premature ventricular extrasystoles ( = 0.043), and there was an association with prolonged QTc interval ( = 0.052).

CONCLUSIONS

The results show that lower TRAIL is associated with stroke severity, unfavorable functional outcome, and short-term mortality in patients after acute ischemic stroke. Moreover, we described the association with markers of cardiac injury and ECG changes.

摘要

背景

已知肿瘤坏死因子相关凋亡诱导配体(TRAIL)与心血管事件后的不良预后相关。我们旨在评估急性卒中患者TRAIL水平的动态变化、TRAIL水平与卒中严重程度的关系、其对短期预后的影响以及与心脏损伤标志物的关联。

方法

在2020年8月至2021年8月期间,我们纳入了120例连续患者,其中104例为急性缺血性卒中(AIS)患者,76例接受了再灌注治疗,16例为脑出血(ICH)患者。在入院时、24小时后和48小时后采集患者血液样本,以测定血浆肿瘤坏死因子相关凋亡诱导配体(TRAIL)、脑钠肽N端前体(NT-proBNP)和高敏肌钙蛋白I(hs-TnI)水平。在入院时、24小时后、48小时后以及患者出院时记录12导联心电图。入院时使用美国国立卫生研究院卒中量表(NIHSS)进行评估,患者出院90天后使用改良Rankin量表(mRS)进行评估。

结果

我们观察到第一天较低的TRAIL水平与使用NIHSS评估的卒中严重程度之间存在关联(P = 0.044)。较低的TRAIL水平在住院24小时(P = 0.0022)和48小时(P = 0.044)后,与90天时使用mRS评估的严重残疾和死亡相关。此外,我们观察到入院时(P = 0.039)、住院24小时后(P = 0.043)和48小时后(P = 不完整,请补充完整后继续追问)较低的TRAIL水平与NT-proBNP升高之间存在关联。在心电图分析中,较低的TRAIL水平与室性早搏的发生相关(P = 0.043),并且与QTc间期延长相关(P = 0.052)。

结论

结果表明,较低的TRAIL水平与急性缺血性卒中患者的卒中严重程度、不良功能结局和短期死亡率相关。此外,我们描述了其与心脏损伤标志物和心电图变化的关联。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验